METHODS AND COMPOSITIONS FOR CLASSIFYING AND TREATING BLADDER CANCER

Abstract

The invention provides methods for classifying bladder cancer (e.g., urothelial cancer (UC), e.g., locally advanced or metastatic UC); methods for treating bladder cancer in a patient, for example, by administering a treatment regimen that comprises a PD-1 axis binding antagonist (e.g., atezolizumab) to the patient. Also provided are compositions for use, kits, and articles of manufacture for use in classifying and treating bladder cancer in a patient.

CPC Classifications